Abstract
The main aim of the present research was to synthesize carbohydrate (d-gluconic acid, DGA) prodrug of methotrexate (MTX) to improve the aqueous solubility and to develop mixed micelles (MMs) composed of d-α-tocopheryl poly (ethylene glycol) 1000 succinate (TPGS) as an MDR reversing copolymer and poloxamer 407 (P-407) to deliver the MTX prodrug to tumor tissue via enhanced permeability and retention (EPR) mechanism. MTX-DGA conjugate (MDGAC) was synthesized using Steglich esterification reaction. The MDGAC-loaded TPGS and P-407 MMs (MDGAC-TP MMs) were prepared by solvent evaporation technique. MDGAC-TP MMs showed low critical micelle concentration, high drug loading, sustained release profile, lower hemolytic behavior, higher in vitro cytotoxicity against the human carcinoma cell lines KB and MDR KBv, and significantly reduced in vivo toxicity. Therefore, the developed MDGAC-TP MMs could be a promising and effective approach for the development and treatment of MDR tumors.
Similar content being viewed by others
References
Liang L, Lin SW, Dai W, Lu JK, Yang TY, Xiang Y, Zhang Y, Li RT, Zhang Q (2012) Novel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicity. J Control Release 160:618–629
Feng SS, Chien S (2003) Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci 58:4087–4114
Huang K, Shi B, Xu W, Ding J, Yang Y, Liu H, Zhuang X, Chen X (2015) Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety. Acta Biomater 27:179–193
Fu Q, Lv P, Chen Z, Ni D, Zhang L, Yue H, Yue Z, Wei W, Ma G (2015) Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale 7:4020–4030
Zhang Y, Jin T, Zhuo RX (2005) Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release. Colloids Surf B: Biointerfaces 44(2–3):104–109
Banerjee D, Mayer KP, Capiaux G, Budak AT, Gorlick R, Bertino JR (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 1587(2–3):164–173
Lorico A, Toffoli G, Boiocchi M, Ma D (1988) Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5, 8-dideazafolic acid. Cancer Res 48(8):2036–2041
Berger W, Setinek U, Hollaus P, Zidek T, Steiner E, Elbling L, Cantonati H, Attems J, Gsur A, Micksche M (2005) Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol 131(6):355–363
Thomas H, Coley HM (2003) Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 10(2):159–165
Garcion E, Lamprecht A, Heurtault B, Paillard A, Pouessel AA, Denizot B, Menei P, Benoît JP (2006) A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5(7):1710–1722
Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P (2003) Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release 93(2):151–160
Koziara JM, Whisman TR, Tseng MT, Mumper RJ (2006) In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release 112(3):312–319
Minko T, Kopecková P, Pozharov V, Kopeck J (1998) HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release 54(2):223–233
Minko T, Kopecková P, Kopeck J (2001) Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer bound doxorubicin in human ovarian carcinoma cells. J Control Release 71(3):227–237
Batrakova VE, Kelly DL, Kabanov AV (2006) Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm 3(2):113–123
Matsumura Y (2007) Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles. J Drug Target 15(7–8):507–517
Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X (2009) Paclitaxel-loaded pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 376(1–2):176–185
Kim D, Lee ES, Park K, Kwon IC, Bae YH (2008) Doxorubicin loaded pH-sensitive micelles: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res 25(9):2074–2082
Liu J, He Y, Zhang J, Li J, Yu X, Cao Z, Meng F, Zhao Y, Wu X, Shen T, Hong Z (2016) Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery. Biomaterials 74:64–76
Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z (2014) D-a-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm 11:3196–3209
Guo Y, Luo J, Tan S, Otieno BO, Zhang Z (2013) The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 49:175–186
Sang V, Sanjib K (2010) Synthesis, characterization, and biological evaluation of poly (L-glutamyl-glutamine) paclitaxel nanoconjugate. J Control Release 3:38–45
Manjappa AS, Kumbhar PS, Khopade PS, Patil AB, Disouza JI (2018) Mixed micelles as nano polymer therapeutics of docetaxel: increased in vitro cytotoxicity and decreased in vivo toxicity. Curr Drug Deliv 15(4):564–575
Shi C, Zhang Z, Wang F, Ji X, Zhao Z, Luan Y (2015) Docetaxel loaded PEO-PPOPCL/TPGS mixed micelles for overcoming multidrug resistance and enhancing antitumor efficacy. J Mater Chem B 20(3):4259–4271
Yanzuo C, Wei Z, Jijin G, Qiuyue R, Zhuoyang F, Weitong Z, Xiaoling F, Xianyi S (2013) Enhanced antitumor efficacy by methotrexate conjugated pluronic mixed micelles against KBv multidrug resistant cancer. J Pharm 452(1-2):421–433
Yanzuo C, Xianyi S, Wei Z, Weitong Z, Zhuoyang F, Qiuyue R, Liangcen C, Xiaoling F (2013) Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomedicine 8:1463–1476
Jindal N, Mehta SK (2015) Nevirapine loaded poloxamer 407/pluronic P123 mixed micelles: optimization of formulation and in vitro evaluation. Colloids Surf B: Biointerfaces 129(1):100–106
Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic block copolymer as novel polymer therapeutics for drug and gene delivery. J Control Release 82(2–3):189–212
Wunder A, Stehle G, Schrenk HH, Hartung G, Heene DL, Maier BW, Sinn H (1998) Antitumor activity of methotrexate-albumin conjugates in rats bearing a walker-256 carcinoma. Int J Cancer 76(6):884–890
Gholamhossein Y, Seyed MF, Afshin Z, Alireza S (2010) Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system. Chem Pharm Bull 58(2):147–153
Kasim NA, Whitehouse M, Ramachandran C et al (2003) Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1:85–96
Ronak SB, Ankitkumar SJ, Dinesh TM, Aarti GJ, Puthusserickal AR et al (2016) Soluplus based polymeric micelles and mixed micelles of lornoxicam: design, characterization and in vivo efficacy studies in rats. Ind J Pharm Edu Res 50(2):77–86
Zhang W, Junguo H, Shi Y, Yajuan L, Wu J, Xianyi S, Xiaoling F (2009). Int J Pharm 376:185
Saxena V, Hussain MD (2012) Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine 7:713–721
Manjappa AS, Kumbhar PS, Patil AB, Disouza JI, Patravale VB (2018) Drug loaded polymeric mixed micelles: suitable approach to improve therapeutic performance of single copolymer micelles. Crit Rev Ther Drug Carr Syst 36(1):1–58
Zhao D, Zhang H, Yang S, He W, Luan Y (2016) Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: an efficient drug delivery system for overcoming multidrug resistance. Int J Pharm 515:281–292
Maria AG, Silvia P, Cristina P, Patrizia S, Angel C, Carmen AL, Sara N (2018) Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery. Mol Pharm 15(2):571–584
Wang F, Zhang D, Zhang Q, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y (2011) Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to over-come multi-drug resistance. Biomaterials 32:9444–9456
Batrakova EV, Kabanov AV (2008) Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98–106
Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, Erhan SZ, Wu XY (2006) A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res 23(7):1574–1585
Acknowledgements
We are greatly thankful to our Head of Institute and Institute Management for supporting this research project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Kumbhar, P.S., Birange, S., Atavale, M. et al. d-Gluconic acid–based methotrexate prodrug–loaded mixed micelles composed of MDR reversing copolymer: in vitro and in vivo results. Colloid Polym Sci 296, 1971–1981 (2018). https://doi.org/10.1007/s00396-018-4416-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00396-018-4416-6